Literature DB >> 15694150

Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites.

Dong-Joon Park1, Byung-Ho Choi, Shi-Jiang Zhu, Jin-Young Huh, Byung-Young Kim, Seoung-Ho Lee.   

Abstract

AIM: Several injectable materials have been used as osteogenic bone substitutes. However, none has gained universal acceptance. This study was performed to investigate whether or not chitosan-alginate gel/mesenchymal stem cells/bone morphogenetic protein-2 composites are potentially injectable materials for new bone formation.
MATERIAL AND METHODS: The composites were injected into the subcutaneous space on the dorsum of nude mice to investigate new bone tissue formation. The composites were examined histologically over a 12-week period.
RESULTS: The composites injected into the mouse were able to stimulate new bone formation, which was trabecular in type.
CONCLUSIONS: This study showed that chitosan-alginate gel/MSCs/BMP-2 composites could become clinically useful injectable materials to generate new bone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694150     DOI: 10.1016/j.jcms.2004.05.011

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  17 in total

1.  Alginate: properties and biomedical applications.

Authors:  Kuen Yong Lee; David J Mooney
Journal:  Prog Polym Sci       Date:  2012-01       Impact factor: 29.190

2.  Injectable tissue-engineered bone repair of a rat calvarial defect.

Authors:  Scott J Stephan; Sunil S Tholpady; Brian Gross; Caren E Petrie-Aronin; Edward A Botchway; Lakshmi S Nair; Roy C Ogle; Stephen S Park
Journal:  Laryngoscope       Date:  2010-05       Impact factor: 3.325

3.  Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells.

Authors:  Lisa Haines-Butterick; Karthikan Rajagopal; Monica Branco; Daphne Salick; Ronak Rughani; Matthew Pilarz; Matthew S Lamm; Darrin J Pochan; Joel P Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

Review 4.  Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends.

Authors:  J F Mano; G A Silva; H S Azevedo; P B Malafaya; R A Sousa; S S Silva; L F Boesel; J M Oliveira; T C Santos; A P Marques; N M Neves; R L Reis
Journal:  J R Soc Interface       Date:  2007-12-22       Impact factor: 4.118

5.  Rational design of hydrogels to enhance osteogenic potential.

Authors:  Soyon Kim; Min Lee
Journal:  Chem Mater       Date:  2020-11-05       Impact factor: 9.811

Review 6.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

7.  Integration of a novel injectable nano calcium sulfate/alginate scaffold and BMP2 gene-modified mesenchymal stem cells for bone regeneration.

Authors:  Xiaoning He; Rosemary Dziak; Keya Mao; Robert Genco; Mark Swihart; Mark Swithart; Chunyi Li; Shuying Yang
Journal:  Tissue Eng Part A       Date:  2012-11-16       Impact factor: 3.845

8.  Ethyl-3,4-dihydroxybenzoate with a dual function of induction of osteogenic differentiation and inhibition of osteoclast differentiation for bone tissue engineering.

Authors:  Byeong-Ju Kwon; Mi Hee Lee; Min-Ah Koo; Jae-Jin Han; Jong-Chul Park
Journal:  Tissue Eng Part A       Date:  2014-06-23       Impact factor: 3.845

9.  Mutually reinforced multicomponent polysaccharide networks.

Authors:  Laura L Hyland; Marc B Taraban; Boualem Hammouda; Y Bruce Yu
Journal:  Biopolymers       Date:  2011-06-22       Impact factor: 2.505

10.  Mechanical and biological properties of chitosan/carbon nanotube nanocomposite films.

Authors:  Ashkan Aryaei; Ahalapitiya H Jayatissa; Ambalangodage C Jayasuriya
Journal:  J Biomed Mater Res A       Date:  2013-09-24       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.